Loading…
Sectoral / Thematic · quant Mutual Fund · AMFI code 151853quant Healthcare Fund
Disclosed for 38 months, Aug 2023 to Sep 2026.
Portfolio value
₹162 Cr
up ₹1.3 Cr vs Sep 2023
- Stocks held
- 14
- down 3 vs Sep 2023
- Top 10 weight
- 75.1%
- of the portfolio in its ten largest
- Cash & debt
- 3.0%
- cash, money market and debt
- Moves this month
- 1 in · 4 out
quant Healthcare Fund is an active equity fund in the Sectoral / Thematic category from quant Mutual Fund. In October 2023 it disclosed 14 stocks worth ₹162 Cr, up ₹1.3 Cr from Sep 2023. Its largest positions were Reliance Industries Limited (10.0%), Aster DM Healthcare Limited (9.0%), Poly Medicure Limited (8.8%); the ten largest together made up 75.1% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 55.2% of its equity. Cash and debt stood at 3.0%. Compared with Sep 2023 the fund entered 1 new stock and exited 4.
Against 229 other Sectoral / Thematic funds
Concentration
96%
Top-10 weight is higher than 96% of peers
Breadth
2%
Holds more stocks than 2% of peers
Cash
43%
Holds more cash than 43% of peers
What these mean: concentration · cash
Holdings in October 2023
Download CSVEvery line the fund disclosed, with the change against Sep 2023. Click a column to sort; click a company to see every fund that owns it. New to these? How to read a portfolio.
| Reliance Industries Limited | 10.04% | up 0.69 pts | ₹16.2 Cr | up ₹1.2 Cr | Added |
| Aster DM Healthcare Limited | 9.01% | up 0.83 pts | ₹14.6 Cr | up ₹1.5 Cr | Added |
| Poly Medicure Limited | 8.79% | up 0.13 pts | ₹14.2 Cr | up ₹32 L | Added |
| Sun Pharmaceutical Industries Limited | 8.12% | down 0.59 pts | ₹13.1 Cr | down ₹84 L | Trimmed |
| GlaxoSmithKline Pharmaceuticals Limited | 8.01% | up 2.99 pts | ₹13 Cr | up ₹4.9 Cr | Added |
| IPCA Laboratories Limited | 6.69% | up 0.27 pts | ₹10.8 Cr | up ₹53 L | Added |
| Cipla Limited 30/11/2023 Derivative | 6.54% | up 6.54 pts | ₹10.6 Cr | up ₹10.6 Cr | New |
| Indoco Remedies Limited | 6.30% | down 0.48 pts | ₹10.2 Cr | down ₹68 L | Trimmed |
| Aurobindo Pharma Limited 30/11/2023 Derivative | 6.27% | up 6.27 pts | ₹10.1 Cr | up ₹10.1 Cr | New |
| Sequent Scientific Limited | 5.31% | up 1.73 pts | ₹8.6 Cr | up ₹2.8 Cr | Added |
| Lupin Limited 30/11/2023 Derivative | 4.48% | up 4.48 pts | ₹7.2 Cr | up ₹7.2 Cr | New |
| Aarti Drugs Limited | 4.10% | up 2.47 pts | ₹6.6 Cr | up ₹4 Cr | Added |
| AstraZeneca Pharma India Limited | 3.36% | up 0.10 pts | ₹5.4 Cr | up ₹20 L | Added |
| Cash, TREPS & receivables | 3.03% | up 8.75 pts | ₹4.9 Cr | up ₹14.1 Cr | Added |
| Granules India Limited | 2.82% | down 0.28 pts | ₹4.6 Cr | down ₹40 L | Trimmed |
| Alembic Pharmaceuticals Limited | 2.29% | up 2.29 pts | ₹3.7 Cr | up ₹3.7 Cr | New |
| Granules India Limited 30/11/2023 Derivative | 1.42% | up 1.42 pts | ₹2.3 Cr | up ₹2.3 Cr | New |
| Kopran Limited | 1.41% | down 0.02 pts | ₹2.3 Cr | down ₹1 L | Trimmed |
| BROOKS Laboratories Limited | 1.06% | down 0.96 pts | ₹1.7 Cr | down ₹1.5 Cr | Trimmed |
| Sun Pharmaceutical Industries Limited 30/11/2023 Derivative | 0.95% | up 0.95 pts | ₹1.5 Cr | up ₹1.5 Cr | New |
What changed, Sep 2023 to Oct 2023
New New positions (1)
- Alembic Pharmaceuticals Limited2.3% · ₹3.7 Cr
Exited Exited (4)
- Piramal Pharma Limitedwas 6.6% · ₹10.5 Cr
- Fortis Healthcare Limitedwas 6.0% · ₹9.7 Cr
- Apollo Hospitals Enterprise Limitedwas 2.8% · ₹4.5 Cr
- Gufic Biosciences Limitedwas 2.3% · ₹3.6 Cr
Added Biggest additions
- GlaxoSmithKline Pharmaceuticals Limitedup ₹4.9 Cr (+2.99% pts)
Sectors
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Where the weight moved
Compared with
Since Sep 2023, the weight rose most in Pharmaceuticals & Biotechnology (+5.1 pts) and Petroleum Products (+2.0 pts), and fell most in Healthcare Services (−8.5 pts).
- Pharmaceuticals & Biotechnology50.1% → 55.2%+5.1 pts
- Petroleum Products11.2% → 13.2%+2.0 pts
- Healthcare Equipment & Supplies10.3% → 11.5%+1.2 pts
- Pharmaceuticals8.1% → 8.3%+0.2 pts
- Healthcare Services20.3% → 11.8%−8.5 pts
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
Main sectors’ weights over time
| Sector | Sep 2023 | Oct 2023 |
|---|---|---|
| Pharmaceuticals & Biotechnology | 50.1% | 55.2% |
| Petroleum Products | 11.2% | 13.2% |
| Healthcare Services | 20.3% | 11.8% |
| Healthcare Equipment & Supplies | 10.3% | 11.5% |
| Pharmaceuticals | 8.1% | 8.3% |
Allocation in Oct 2023change vs Sep 2023
- Pharmaceuticals & Biotechnology (9)55.2%▲ 5.1 pts
- Petroleum Products (1)13.2%▲ 2.0 pts
- Healthcare Services (1)11.8%▼ 8.5 pts
- Healthcare Equipment & Supplies (1)11.5%▲ 1.2 pts
Cash and debt
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal. More on reading cash.
Cash & debt, Oct 2023
3.0%
▲ 2.5 pts vs Sep 2023
- Cash alone
- 3.0%
- cash and net receivables
- A year earlier
- —
- no disclosure
- Last 12 months
- 0.5% – 3.1%
- lowest to highest · record 3.1% in Aug 2023
History
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.